Increased plasma levels of adrenomedullin in patients with hypertrophic cardiomyopathy: Its relation to endothelin-1, natriuretic peptides and noradrenaline

Clinical Science

Volumn 94, Issue 1, 1998, Pages 21-28

  Hamada, Mareomi ^a   Shigematsu, Yuji ^a   Kawakami, Hideo ^a   Minamino, Naoto ^b   Kangawa, Kenji ^b   Matsuo, Hisayuki ^b   Hiwada, Kunio ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Adrenomedullin; Atrial natriuretic peptide; Brain natriuretic peptide; Endothelin 1; Hypertrophic cardiomyopathy; Noradrenaline

Indexed keywords

ADRENOMEDULLIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CREATININE; ENDOTHELIN 1; NORADRENALIN; PROTEIN ANTIBODY;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ECHOCARDIOGRAPHY; HEART RATE; HEMODYNAMICS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY;

EID: 0031975787     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0940021     Document Type: Article

References (37)

1. Kitamura K, Kangawa K, Kawamoto M, et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192: 553-60.
2. Ishimitsu T, Nishikimi T, Saito Y, et al. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest 1994; 94: 2158-61.
3. Nishikimi T, Saito Y, Kitamura K, et al. Increased plasma levels of adrenomedullin In patients with heart failure. J Am Coll Cardiol 1995; 26: 1424-31.
4. Jougasaki M, Wei C-M, McKinley LJ, Burnett Jr JC. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation 1995; 92: 286-9.
5. Jougasaki M, Rodeheffer RJ, Redfield MM, et al. Cardiac secretion of adrenomedullin in human heart failure. J Clin Invest 1996; 97: 2370-6.
6. Richards AM, Nicholls MG, Lewis L, Lainchbury JG. Adrenomedullin. Clin Sci 1996; 91: 3-16.
7. Nishikimi T, Kitamura K, Saito Y, et al. Clinical studies on the sites of production and clearance of circulating adrenomedullin in human subjects. Hypertension 1994; 24: 600-4.
8. Sugo S, Minamino N, Kangawa K, et al. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 1994; 201: 1160-6.
9. Sugo S, Minamino N, Shoji H, et al. Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor-α. Biochem Biophys Res Commun 1994; 203: 719-26.
10. Sugo S, Minamino N, Shop H, et al. Interleukin-1, tumor necrosis factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular muscle cells. Biochem Biophys Res Commun 1995; 207: 25-31
11. Minamino N, Shoji H, Sugo S, et al. Adrenocortical steroids, thyroid hormones and retinotc acid augment the production of adrenomedullin in vascular smooth muscle cells. Biochem Biophys Res Commun 1995; 211: 686-93.
12. Ishizaka Y, Ishizaka Y, Tanaka M, et al. Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells. Biochem Biophys Res Commun 1994; 200: 642-6.
13. 2+ mobilization, in bovine aortic endothelial cells. J Biol Chem 1995; 270: 4412-7.
14. Maron BJ, Wolfson JK, Epstein SE, Roberts WC. Intramural ('small vessel') coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 1986; 8: 545-57.
15. Tanaka M, Fujiwara H, Onodera T, et al. Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy. Circulation 1987; 75: 1130-9.
16. Camici P, Chiriatti G, Lorenzoni R, et al. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1991; 17: 879-86.
17. Dilsizian V, Bonow RO, Epstein SE, Fananapazir L. Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1993; 22: 796-804.
18. Hamada M, Ohtani T, Sekiya M, et al. Serum creatine kinase MM isoforms in hypertrophic cardiomyopathy. Clin Sci 1991; 81: 723-6.
19. Dollar A, Roberts WC. Usefulness of total 12-lead QRS voltage compared with other criteria for determining left ventricular hypertrophy in hypertrophic cardiomyopathy: analysis of 57 patients studied at necropsy. Am J Med 1989; 87: 377-81.
20. Sahn DJ, DeMaria A, Kisslo J, Weyman A. The Committee on M-mode Standardization of The American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography. results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-83.
21. Hamada M, Shigematsu Y, Mukai M, Kazatani Y, Kokubu T, Hiwada K. Blood pressure response to the Valsalva maneuver in pheochromocytoma and pseudopheochromocytoma. Hypertension 1995; 25: 266-71.
22. Teichholtz LE, Kreulent T, Herman MV. Problems in echocardiographic volume determinations; echocardiographic and angiographic correlation in the presence or absence of asynergy. Am J Cardiol 1976; 37: 7-14.
23. Kato J, Kobayashi K, Etoh T, et al. Plasma adrenomedullin concentration in patients with heart failure. J Clin Endocrinol Metab 1996; 81: 180-3.
24. Ichiki Y, Kitamura K, Kangawa K, Kawamoto M, Matsuo H, Eto T. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett 1994; 338: 6-10.
25. Kitamura K, SakataJ, Kangawa K, Kojima M, Matsuo H, Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun 1993; 194: 720-5.
26. Kawakami H, Okayama H, Hamada M, Hiwada K. Alteration of atrial natriuretic peptide and brain natriuretic peptide gene expression associated with progression and regression of cardiac hypertrophy in renovascular hypertensive rats. Clin Sci 1996; 90: 197-204.
27. Margulies KB, Hildebrand FL, Lerman A, Perrella MA, Burnett JC. Increased endothelin-1 in experimental heart failure. Circulation 1990; 82: 2226-30.
28. Hiroe M, Hirata Y, Fujita N, et al. Plasma endothelin-1 levels in idiopathic dilated cardiomyopathy. Am J Cardiol 1991; 68: 1114-15.
29. McMurray JJ, Ray SG, Abdullah I, Dargie HJ, Morton JJ. Plasma endothelin in chronic heart failure. Circulation 1992; 85: 1374-9.
30. Stewart OJ, Cernacek P, Costello KB, Rouleau JL. Elevated endothelin-1 in heart failure and loss of normal response to postural change. Circulation 1992; 85: 510-17.
31. Hasegawa K, Fujiwara H, Koshiji M, et al. Endothelin-1 and its receptor in hypertrophic cardiomyopathy. Hypertension 1996; 27: 259-64.
32. Stewart DJ, Baffour R. Functional state of the endothelium determines the response to endothelin In the coronary circulation. Cardiovasc Res 1990; 24: 7-12.
33. Ezra D, Goldstein RE, Czaja JF, Feuerstein GZ. Lethal ischemia due to intracoronary endothelin in pigs. Am J Physiol 1989; 257: H339-43.
34. Larkin SW, Clarke JG, Keogh BE, et al. Intracoronary endothelin induces myocardial ischemia by small vessel constriction in the dog. Am J Cardiol 1989; 64: 956-8.
35. Shubeita HE, McDonough PM, Harris AN, et al. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes: a paracrine mechanism for myocardial cell hypertrophy. J Biol Chem 1990; 265: 20555-62.
36. Ito H, Hirata Y, Hiroe M, et al. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res 1991; 69: 209-15.
37. Cheung B, Leung R. Elevated plasma levels of human adrenomedullin in cardiovascular, respiratory, hepatic and renal diseases. Clin Sci 1997; 92: 59-62.